148 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

Page of 3 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Group enriched
ACHEAcetylcholinesterase (Yt blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ALPPL2Alkaline phosphatase, placental-like 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
AMY2AAmylase, alpha 2A (pancreatic)Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
AOC3Amine oxidase, copper containing 3Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
BCHEButyrylcholinesteraseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
BGLAPBone gamma-carboxyglutamate (gla) proteinFDA approved drug targets
Predicted secreted proteins
Mixed
BLVRBBiliverdin reductase B (flavin reductase (NADPH))Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
C3Complement component 3Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
C4AComplement component 4A (Rodgers blood group)Blood group antigen proteins
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
C4BComplement component 4B (Chido blood group)Blood group antigen proteins
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
C5Complement component 5Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CARTPTCART prepropeptideFDA approved drug targets
Predicted secreted proteins
Tissue enriched
CCL2Chemokine (C-C motif) ligand 2Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
CD2CD2 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD3DCD3d molecule, delta (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD4CD4 moleculeCD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
CD44CD44 molecule (Indian blood group)Blood group antigen proteins
Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
CD80CD80 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CD86CD86 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Mixed
CES1Carboxylesterase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
CHRNA2Cholinergic receptor, nicotinic, alpha 2 (neuronal)Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
CKMT1ACreatine kinase, mitochondrial 1AEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted secreted proteins
Mixed
CKMT1BCreatine kinase, mitochondrial 1BEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted secreted proteins
Tissue enhanced
CSF2RAColony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CTLA4Cytotoxic T-lymphocyte-associated protein 4CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
CYP17A1Cytochrome P450, family 17, subfamily A, polypeptide 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
DBHDopamine beta-hydroxylase (dopamine beta-monooxygenase)Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
DDR2Discoidin domain receptor tyrosine kinase 2CD markers
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Mixed
DPEP1Dipeptidase 1 (renal)Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enhanced
DPP4Dipeptidyl-peptidase 4CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
EGFREpidermal growth factor receptorCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
ELANEElastase, neutrophil expressedCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
F10Coagulation factor XCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
F11Coagulation factor XICandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
F2Coagulation factor II (thrombin)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enriched
F5Coagulation factor V (proaccelerin, labile factor)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Group enriched
F7Coagulation factor VII (serum prothrombin conversion accelerator)Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
F8Coagulation factor VIII, procoagulant componentCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
F9Coagulation factor IXCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FCGR1BFc fragment of IgG, high affinity Ib, receptor (CD64)FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
FCGR3AFc fragment of IgG, low affinity IIIa, receptor (CD16a)CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
FGAFibrinogen alpha chainCancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FGFR1Fibroblast growth factor receptor 1Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Expressed in all
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FLT4Fms-related tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FN1Fibronectin 1Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
FSHRFollicle stimulating hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
Group enriched

Page of 3 | next »